X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.55
Delayed Data
As of Mar 27
 +0.31 / +13.84%
Today’s Change
1.55
Today|||52-Week Range
5.04
+28.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
AssetsCash2.9M2.6M2.9M2.3M
 
 
 
 
 
Short Term Investment Cash-1.3M-296.9K83.2K-311.7K
 
 
 
 
 
Cash & Short Term Investments2.9M2.6M3.4M2.8M
 
 
 
 
 
 
ReceivablesReceivables493.0K688.0K675.0K727.7K
 
 
 
 
 
 
InventoriesInventories302.0K208.0K301.0K215.4K
 
 
 
 
 
 
Current AssetsPrepaid Expenses106.0K------
 
 
Other Current Assets1.3M1.3M-0.000.00
 
 
 
 
Current Assets5.1M4.8M4.4M3.8M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross161.0K------
 
 
Depreciation-100.0K------
 
 
Intangible Assets2.9M2.9M2.8M2.7M
 
 
 
 
 
Other Assets2.9M2.9M2.8M2.7M
 
 
 
 
 
Total Assets8.0M7.7M7.2M6.5M
 
 
 
 
 
 
LiabilitiesAccounts Payable615.0K379.0K525.0K469.6K
 
 
 
 
 
Accrued Expenses239.0K------
 
 
Other Current Liabilities405.0K926.0K823.0K679.2K
 
 
 
 
 
Other Liabilities1.2M1.3M1.3M1.1M
 
 
 
 
 
 
Total LiabilitiesTotal Liabilities1.2M1.3M1.4M1.2M
 
 
 
 
 
 
EquityMinority Interest-681.7K-76.3K-149.9K-57.1K
 
 
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity6.3M6.1M5.7M5.2M
 
 
 
 
 
Total Shareholder Equity6.3M6.1M5.7M5.2M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding11.3M11.6M11.8M11.9M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.
 

To view my watchlist

Not a member yet?

Sign up now for a free account